-
In patients with suspected pulmonary tuberculosis who are unable to expectorate sputum, culture of 3 induced sputum samples, all collected on the same day, is an effective and efficient means of diagnosis.
-
A prodrug of dextroamphetamine has been approved by the FDA for the treatment of attention-deficit/hyperactivity disorder (ADHD). Lisdexamfetamine is the d-amphetamine covalently bound to l-lysine. It is marketed by Shire US Inc as Vyvanse.
-
Statin-treated patients who developed symptoms of myopathy should be treated with at least 100 mg daily of coenzyme Q10 for a minimum of 30 days (assuming CPK values and/or other liver function tests are not abnormal) before discontinuing statin therapy.
-
The FDA has approved the first continuous, low dose, oral contraceptive for the prevention of pregnancy.
-
Almost 90% of persons with type 2 diabetes (DM2) are overweight. Weight loss in DM2 consistently results in meaningful favorable changes in lipids, glucose, and insulin resistance, so the clinical community embraces tools to enhance weight loss in this population.
-
In this article, the ECG in the Figure was obtained from a 33-year old man who was admitted to the hospital with atypical chest pain.
-
Limiting dietary sodium can reduce blood pressure and morbidity and mortality from cardiovascular disease.
-
In a systematic review and meta-analysis of worldwide data on the placement of ureteral stents after ureteroscopy in patients with kidney stones, the authors found higher morbidity with lower urinary tract problems ...
-
This study documents the safety and efficacy of oral polyethylene glycol for the long-term treatment of chronic constipation.
-
GlaxoSmithKline's rosiglitazone (Avandia) will receive a black box warning by the FDA because of concerns over heart failure associated with use of the drug.
